This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Mr. Baron Night, CEO of SOHM Inc., is pleased to announce the appointment of Dr. Wei Zhu as the company's Senior Marketing and Sales Consultant, effective immediately.

Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the journal Human Gene ...

The company expects the trial to support the submission of a biologics license application with the US Food and Drug Administration in 2026.

Cell density is a broadly applicable tool for guiding engineered and naturally occurring cells to build a vast array of structures, tissues, and organs.

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a ...